MRD measurement and BSRI are bringing us closer to cure

| Jim Omel

Patients understand that improved treatment for myeloma can result in unprecedented depth of response, and myeloma treatment has changed dramatically in the last few years. Prior to 1997 when I was diagnosed, complete response (CR) was defined as a 75% reduction in M-protein. Stringent CR (sCR) did not exist because this deep level of control […]

Then and Now

| Yelak Biru

A diagnosis of terminal disease such as myeloma makes us question our place in the universe. It may sometimes create an emptiness and despair that may seem to only get worse with the uncertainty of treatment and outcomes. As of the 2016 58th American Society of Hematology (ASH) meeting, myeloma is not yet curable. All […]